Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 51: 1985-1987, 2005. First published August 11, 2005; 10.1373/clinchem.2005.053181
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
clinchem.2005.053181v1
51/10/1985    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Web of Science (9)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Inganäs, M.
Right arrow Articles by Andersson, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Inganäs, M.
Right arrow Articles by Andersson, P.
Related Collections
Right arrow Oak Ridge Conference
Right arrow Point-of-Care Testing
Right arrow Proteomics and Protein Markers
Right arrow Endocrinology and Metabolism
Right arrow Automation and Analytical Techniques
(Clinical Chemistry. 2005;51:1985-1987.)
© 2005 American Association for Clinical Chemistry, Inc.

Abstracts of Oak Ridge Posters

Integrated Microfluidic Compact Disc Device with Potential Use in Both Centralized and Point-of-Care Laboratory Settings

Mats Inganäsa, Helene Dérand, Ann Eckersten, Gunnar Ekstrand, Ann-Kristin Honerud, Gerald Jesson, Gunnar Thorsén, Tobias Söderman and Per Andersson

Gyros AB, Uppsala Science Park, SE-751 83 Uppsala, Sweden;

aauthor for correspondence: fax 46-18-566352, e-mail mats.inganas@gyros.com)

The first 20% of the full text of this article appears below.

Reducing the size of reaction volumes in immunodiagnostic procedures can reduce not only reagent cost but also analysis time. With reduced sample and reagent volumes and use of a flow-through mode, reactions reach completion rapidly, potentially decreasing turnaround time and making such systems suitable for point-of-care testing. However, decreased reaction volumes typically lead to other problems, such as imprecision of liquid metering, liquid evaporation, and problems related to the increased surface-to-volume ratio.

To address these challenges, we have developed a new bioanalytical system composed of a disposable microfluidic compact disc (CD) device (Gyrolab BioaffyTM) that is intended for sandwich immunoassays and an instrument for automatic processing of CDs (GyrolabTM Workstation).

The Gyrolab Bioaffy CD (diameter, 120 mm) contains 104 parallel microstructures conveniently fitting into the CD, each covering a surface area of ~2 x 15 mm. The CD is manufactured by injection molding using a cycloolefin polymer. The CD is covered with a lid in which appropriately placed holes enable liquid introduction by the robot into the microstructures; the lid protects liquids from evaporation once in the CD. Liquid movement and localization are achieved by a combination of capillary action, centrifugal force, and hydrophobic barriers within the microstructure. Each microstructure contains a 15-nL particle-based column coupled with streptavidin in which reactions take place (Fig. 1 ).


Figure Removed (Available Only in the Full Text)
View larger version (62K):
[in this window]
[in a new window]
  		Figure 1. Gyrolab Bioaffy CD for sandwich immunoassay.

The Gyrolab Bioaffy is designed to be an open system; i.e., it is compatible with various assays that use biotinylated reagents, . . . [Full Text of this Article]






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the American Association for Clinical Chemistry.